Share this on : Facebook Friendfeed Posterous Tumblr Twitter
AC Immune/Genentech to Partner on R&D for Alzheimer’s Antibody; $418M Agree’t
AC Immune has entered into a second exclusive worldwide license agreement and research collaboration with Genentech,of the Roche Group, for the research, development and commercialization of AC Immune’s anti-Tau antibodies for the potential treatment of Alzheimer’s disease and other neurodegenerative diseases. The agreement is valued at $400M.
International & MA Cancer R&D Clusters Showcased at Whitehead Institute
Four Boston-area startups were showcased in an international program on collaborative cancer research & therapy clusters held today at the Whitehead Institute in Cambridge.
UK Life Science Consulting Firm Alacrita To Open US HQ in Cambridge, MA
UK-based Alacrita, a global life science consulting firm, will soon be opening US headquarters in Kendall Square, Cambridge, MA.
Business & Economics, Health, Science, Tech, new cambridge observer, personalized medicine, Technology
Pasteur Institute Spin-out Ariana Pharma Opens Cambridge Office; Analytics Tech to Streamline Clinical Trials
Anita Harris of New Cambridge Observer writes that Ariana Pharma opens Ariana Data Intelligence, Inc., in Cambridge. Ariana offers “KEM” non-statistical analysis technology to streamline and to cut financial risk of clinical trials.
